Accutane vs Winlevi at a glance
| Comparison | Accutane (oral isotretinoin) | Winlevi (clascoterone) |
|---|---|---|
| Treatment format and active drug | Isotretinoin capsules taken by mouth. | Clascoterone 1% cream applied to the skin; Winlevi is clascoterone, not spironolactone. |
| Drug type | A retinoid. | An androgen-receptor inhibitor; its acne mechanism is unknown. |
| Acne role and age | For severe recalcitrant nodular acne in non-pregnant patients age 12 and older who have not responded to conventional therapy. | For topical treatment of acne vulgaris in people age 12 and older. |
| Course and directions | A typical course lasts 15 to 20 weeks. | Apply a thin, even layer twice daily, morning and evening. |
| Pregnancy | Contraindicated in pregnancy and restricted through the iPLEDGE REMS because of embryo-fetal toxicity. | No data are available to evaluate drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. |
| Systemic effects and monitoring | Requires fasting lipid and liver-function tests. | Systemic absorption can occur. HPA-axis suppression is possible; large treatment areas, prolonged use, or occlusion can increase systemic absorption. |
| Skin effects | Common effects include dry lips and dry skin. | May cause local redness, itching, and scaling or dryness; stinging and burning have also been reported. |
Oral isotretinoin and topical clascoterone are different medicines
Accutane means oral isotretinoin, a prescription retinoid whose U.S. label reserves it for severe recalcitrant nodular acne and restricts access through iPLEDGE.
Winlevi contains clascoterone 1%, a topical androgen-receptor inhibitor labeled for acne vulgaris in patients 12 years and older. Winlevi is not spironolactone, and the two names should not be used interchangeably.
Label roles and directions answer different questions
The isotretinoin label describes a 15- to 20-week course for its reserved nodular-acne role. Winlevi labeling gives twice-daily topical directions for acne vulgaris. A 15- to 20-week treatment course and twice-daily application directions measure different things, so they cannot show which medicine works faster.
A clinician should choose between these medicines from the acne type, severity, prior treatment, age, pregnancy context, and safety history.
Pregnancy and systemic-exposure limits matter
Isotretinoin is contraindicated in pregnancy and subject to iPLEDGE. Winlevi uses different pregnancy wording: its label says no pregnancy-use data are available to evaluate drug-associated risks.
Winlevi is topical, but the label reports systemic clascoterone concentrations and possible HPA-axis suppression. It also names large treatment areas, prolonged use, and occlusive dressings as conditions that increase absorption; topical route alone should not be read as zero systemic exposure.
Coordinate any Winlevi treatment change with the prescriber
Ask the clinician managing isotretinoin before adding, stopping, switching, or restarting Winlevi. Use either medicine only as directed and do not create an overlap on your own.
Frequently asked questions
Are Accutane and Winlevi the same medicine?
No. Accutane here means oral isotretinoin capsules. Winlevi is clascoterone 1% cream applied to the skin.
Is Winlevi spironolactone?
No. The Winlevi label identifies clascoterone as its active ingredient and describes it as an androgen-receptor inhibitor. Spironolactone is listed separately in American Academy of Dermatology acne-treatment information.
Does topical Winlevi have no systemic exposure?
No. Topical Winlevi can still produce systemic exposure. Its U.S. label reports measurable clascoterone concentrations, possible HPA-axis suppression, and conditions that can increase absorption.
Do Accutane and Winlevi have the same pregnancy rules?
No. Oral isotretinoin is contraindicated in pregnancy and restricted through iPLEDGE. Winlevi’s label instead says pregnancy-use data are unavailable to evaluate drug-associated risks.
Can Winlevi be used during or after Accutane?
Ask the clinician managing isotretinoin before adding, stopping, switching, or restarting Winlevi. Do not create an overlap or choose a restart date on your own.
Sources
- DailyMed — Isotretinoin capsules prescribing informationDailyMed, U.S. National Library of Medicine
- DailyMed — Winlevi (clascoterone) cream prescribing informationDailyMed, U.S. National Library of Medicine
- American Academy of Dermatology — Acne diagnosis and treatmentAmerican Academy of Dermatology